Predictors of mental disorder in patients with chronic kidney disease
https://doi.org/10.23946/2500-0764-2026-11-1-48-57
Abstract
Aim. To assess the significance of body composition indicators as predictors of the development of cognitive impairment in patients with CKD C5 receiving hemodialysis.
Materials and methods. 182 young and middle-aged CKD C5 patients receiving treatment with chronic hemodialysis were examined. Sarcopenia was diagnosed according to the criteria formulated by the European Working Group on Sarcopenia in Older People (EWGSOP2). To identify dementia and pre-dementia cognitive impairments, all patients were tested using the questionnaire MMSE (Mini-Mental State Examination). The software and hardware complex "Assessment of Nervous System Properties" was used as a tool for studying cognitive functions. The indicators of thinking were evaluated: "simple and complex analogies", linguistic "induction and abstraction".
Results. In patients with CKD C5 receiving hemodialysis, when analyzing the function of thinking, a decrease in the indicator "simple analogies" was recorded in 23 (12.6 %); "complex analogies" in 120 (65.9 %); "language induction" in 173 (95 %) and "language abstraction" in 161 (88.5 %) patients. Patients with CKD C5 and sarcopenia have worse performance of the "language induction" indicator 6 [5; 7] responses, compared with 6 [6; 8] responses in the CKD C5 group and without sarcopenia (p = 0.0434).
Conclusion. Patients with CKD C5 and sarcopenia have cognitive impairment. According to the results of a multivariate regression analysis, sarcopenia indicators, along with age, hemodialysis duration, and biochemical parameters, are the main factors leading to the development of cognitive impairment.
About the Authors
E. V. Utkina
Kemerovo State Medical University
Russian Federation
Russian Federation
Dr. Ekaterina V. Utkina, MD, graduate student at the Department of Faculty Therapy and Occupational Pathology named after Professor V.V. Syrnev
Voroshilova Street, 22A, Kemerovo, 650056
N. V. Fomina
Kemerovo State Medical University ; Kuzbass Regional Clinical Hospital
Russian Federation
Russian Federation
Prof. Natalya V. Fomina, MD, Dr. Sci. (Medicine), Professor, Head of the Department of Faculty Therapy and Occupational Pathology named after Professor V.V. Syrnev
Voroshilova Street, 22A, Kemerovo, 650056
Oktyabrskiy Prospekt, 22, Kemerovo, 650066
References
1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia.Lancet.2019;393(10191):2636– 2646. https://doi.org/10.1016/S0140-6736(19)31138-9
2. Liu T, Wu Y, Cao X, Yang K, Tong Y, Zhang F, et al. Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China Health and Retirement Longitudinal Study. BMC geriatrics. 2024;24(1):134. https://doi.org/10.1186/s12877-024-04691-1
3. Chu NM, Hong J, Harasemiw O, Chen X, Fowler KJ, Dasgupta I, et al. Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011-2014). Nephrol Dial Transplant. 2022;37(11):2180– 2189. https://doi.org/10.1093/ndt/gfab338
4. Hannan M, Steffen A, Quinn L, Collins EG, Phillips SA, Bronas UG. The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review. J Nephrol. 2019;32(2):211– 230. https://doi.org/10.1007/s40620-018-0494-2
5. Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R. Mechanisms of cognitive dysfunction in CKD. Nat. Rev. Nephrol. 2020;16(8):452–469. https://doi.org/10.1038/s41581-020-0266-9
6. Shea YF, Lee MC, Mok MM, Chan FH., Chan TM. Prevalence of cognitive impairment among peritoneal dialysis patients: a systematic review and meta-analysis. Clin Exp Nephrol. 2019;23(10):1221–1234. https://doi.org/10.1007/s10157-019-01762-1
7. Burns CM, Knopman DS, Tupper DE, Davey CS, Slinin YM, Lakshminarayan K., et al. Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease. J Gerontol A Biol Sci Med Sci. 2018;73(3):393–399. https://doi.org/10.1093/gerona/glx241
8. Karakizlis H, Bohl K, Ziemek J, Dodel R, Hoyer J. Assessment of cognitive impairment and related risk factors in hemodialysis patients. J Nephrol. 2022;35(3):931–942. https://doi.org/10.1007/s40620-021-01170-3
9. Levassort H, Boucquemont J, Alencar de Pinho N, Lambert O, Helmer C, Metzger M, et al. A new approach for cognitive impairment pattern in chronic kidney disease. Nephrol Dial Transplant. 2024;39(5):848– 859. https://doi.org/10.1093/ndt/gfad244
10. Fomina NV, Egorova MV, Smakotina SA, Kvitkova LV. S100B protein, neuron specific enolase and cognitive dysfunction in patients with chronic kidney disease. Nephrology (Saint-Petersburg). 2019;23(4):73–79. (In Russ.). https://doi.org/10.24884/1561-6274-2019-23-4-73-79
11. Chu NM, Hong J, Harasemiw O, Chen X, Fowler KJ, Dasgupta I, et al. Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011-2014). Nephrol Dial Transplant. 2022;37(11):2180– 2189. https://doi.org/10.1093/ndt/gfab338
12. Basile G, Sardella A. From cognitive to motor impairment and from sarcopenia to cognitive impairment: a bidirectional pathway towards frailty and disability. Aging Clin Exp Res. 2021;33(2):469–478. https://doi.org/10.1007/s40520-020-01550-y
13. Yang J, Jiang F, Yang M, Chen Z. Sarcopenia and nervous system disorders. J Neurol. 2022;269(11):5787–5797. https://doi.org/10.1007/s00415-022-11268-8
14. Beeri MS, Leugrans SE, Delbono O, Bennett DA, Buchman AS. Sarcopenia is associated with incident Alzheimer's dementia, mild cognitive impairment, and cognitive decline. J Am Geriatr Soc. 2021;69(7):1826–1835. https://doi.org/10.1111/jgs.17206
15. Gasanov MZ, Panchenko MG, Batyushin MM, Gareev RR, Perfilieva AA. Features of cognitive impairment in patients with chronic kidney disease stages 3A-5D: biological value of endothelial nitric oxide synthase. Nephrology (Saint-Petersburg). 2021;25(5):83–91. (In Russ.). https://doi.org/10.36485/1561-6274-2021-25-5-83-91
16. Liu T., Wu Y., Cao X., Yang K., Tong Y., Zhang F., et al. Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China Health and Retirement Longitudinal Study. BMC geriatrics. 2024;24(1):134. https://doi.org/10.1186/s12877-024-04691-1
17. Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M, et al. Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia. Int J Environ Res Public Health. 2017;14(7):809. https://doi.org/10.3390/ijerph14070809
18. Ivanov VI. Svidetel'stvo o gosudarstvennoj registracii programmy dlya EVM № 2023681856 Rossijskaya Federaciya. Ocenka svojstv nervnoj sistemy: № 2023681285: zayavl. 13.10.2023: opubl. 19.10.2023. Zayav. FGBOU VO «Kemerovskij gosudarstvennyj medicinskij universitet» Minzdrav RF. EDN UWGKGE
19. Nikitina AA, Khrulev AE, Kuznetsov AN. Cognitive impairments in patients with chronic kidney disease in the pre-dialysis period. Saratov Scientific and Medical Journal. 2021;17(1):136–142 (In Russ.).
Review
For citations:
Utkina E.V., Fomina N.V. Predictors of mental disorder in patients with chronic kidney disease. Fundamental and Clinical Medicine. 2026;11(1):48-57. (In Russ.) https://doi.org/10.23946/2500-0764-2026-11-1-48-57
Views:
150
JATS XML
Email this article 